Humacyte (HUMA) faces mounting investor scrutiny as a class action lawsuit alleges the company failed to disclose critical manufacturing deficiencies at its Durham, North Carolina facility. These ...

Huma has raised $80 million in funding to expand its AI-driven healthcare platform. The company integrates AI for predictive and diagnostic tools in remote patient monitoring. Funding will support ...

New York, May 16, 2025 (GLOBE NEWSWIRE) -- Huma Therapeutics (“Huma”), the global healthcare AI leader accelerating digital transformation across care and research, today announced two major ...

UK-based Huma has launched today the Huma Cloud Platform, a “Shopify-like” tool for the healthcare ecosystem to design, build, and launch digital health services. “The digitalization of the healthcare ...

Huma, a global healthcare artificial intelligence company, completed a series D funding round of more than $80 million, bringing the company’s valuation to nearly $1 billion, according to Bloomberg.

Digital healthcare company Huma will today announce it has raised $80 million of Series D funding, taking the total amount of investment raised by the company to more than $300 million.

New York, June 05, 2025 (GLOBE NEWSWIRE) -- Huma Therapeutics, the global healthcare AI company, today announced the launch of Hi Scribe, a generative AI clinical documentation tool designed to ...

Humacyte, Inc. (NASDAQ:HUMA) is one of the Best Micro-Cap Stocks to Invest in According to Analysts. In mid-November, Benchmark analyst Bruce Jackson maintained a Buy rating on Humacyte, Inc.

U.K.-based healthcare technology company Huma announced it secured more than $80 million in a Series D funding round, bringing its total raise to over $300 million. New and existing investors, ...

The MarketWatch News Department was not involved in the creation of this content. New York, May 16, 2025 (GLOBE NEWSWIRE) -- Huma Therapeutics ("Huma"), the global healthcare AI leader accelerating ...